Max Healthcare Institute Limited, headquartered in India, has provided an update concerning legal proceedings involving its subsidiary, Kalinga Hospital Ltd (KHL). In a recent disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed about the ongoing petitions filed by the legal representatives of BRS Capital Two Pte. Limited against KHL and Max Healthcare Institute Limited. The proceedings, including interlocutory petitions, were scheduled for a hearing at the Hon’ble National Company Law Tribunal, Cuttack Bench on October 29, 2026.
However, due to a shortage of time, the tribunal could not hear the matter on the scheduled date. The Hon’ble NCLT has adjourned the hearing to October 30, 2026. As of now, no changes in the status of the legal proceedings or development pertaining to the case have been reported. Details of the disclosure have been made available in an annexure enclosed with the filing.
The legal case pertains to Max Healthcare’s acquisition of the majority equity stake in KHL from another shareholder, with the current proceedings initiated by BRS Capital Two Pte. Limited, who have also filed i...